Cell Genomics (Oct 2021)

Association of mitochondrial DNA copy number with cardiometabolic diseases

  • Xue Liu,
  • Ryan J. Longchamps,
  • Kerri L. Wiggins,
  • Laura M. Raffield,
  • Lawrence F. Bielak,
  • Wei Zhao,
  • Achilleas Pitsillides,
  • Thomas W. Blackwell,
  • Jie Yao,
  • Xiuqing Guo,
  • Nuzulul Kurniansyah,
  • Bharat Thyagarajan,
  • Nathan Pankratz,
  • Stephen S. Rich,
  • Kent D. Taylor,
  • Patricia A. Peyser,
  • Susan R. Heckbert,
  • Sudha Seshadri,
  • L. Adrienne Cupples,
  • Eric Boerwinkle,
  • Megan L. Grove,
  • Nicholas B. Larson,
  • Jennifer A. Smith,
  • Ramachandran S. Vasan,
  • Tamar Sofer,
  • Annette L. Fitzpatrick,
  • Myriam Fornage,
  • Jun Ding,
  • Adolfo Correa,
  • Goncalo Abecasis,
  • Bruce M. Psaty,
  • James G. Wilson,
  • Daniel Levy,
  • Jerome I. Rotter,
  • Joshua C. Bis,
  • Claudia L. Satizabal,
  • Dan E. Arking,
  • Chunyu Liu

Journal volume & issue
Vol. 1, no. 1
p. 100006

Abstract

Read online

Summary: Mitochondrial DNA (mtDNA) is present in multiple copies in human cells. We evaluated cross-sectional associations of whole-blood mtDNA copy number (CN) with several cardiometabolic disease traits in 408,361 participants of multiple ancestries in TOPMed and UK Biobank. Age showed a threshold association with mtDNA CN: each additional 10 years of age was associated with a 0.03 SD higher level of mtDNA CN (p = 0.0014) among younger participants (younger than 65 years) versus a 0.14 SD lower level of mtDNA CN (p = 1.82 × 10−13) among older participants (65 years and older). At lower mtDNA CN levels, we found age-independent associations with increased odds of obesity (p = 5.6 × 10−238), hypertension (p = 2.8 × 10−50), diabetes (p = 3.6 × 10−7), and hyperlipidemia (p = 6.3 × 10−56). The observed decline in mtDNA CN after 65 years of age may be a key to understanding age-related diseases.

Keywords